Deferred Income Tax Assets, Net of ADMA BIOLOGICS, INC. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Summary
ADMA BIOLOGICS, INC. quarterly Deferred Income Tax Assets, Net in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • ADMA BIOLOGICS, INC. Deferred Income Tax Assets, Net for the quarter ending 31 Dec 2025 was $73,261,000, a 13% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Change (%)

ADMA BIOLOGICS, INC. Quarterly Deferred Income Tax Assets, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $73,261,000 -$11,019,000 -13% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 $74,433,000 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $79,235,000 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $80,855,000 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $84,280,000 +$84,280,000 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q4 2023 $0 31 Dec 2023 10-K 18 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.